Earnings

Stock Market Today: Dow Falls On New Trump Tariffs; Novo Plunges On Drug Trial Results (Live Coverage)

Stock Market Today: The Dow Jones index dropped Monday on higher Trump tariffs. Novo stock plunged on weight-loss drug trial results.

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

229

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

Psyence Biomedical stock gains on equity investment deal

211

Psyence Biomedical stock gains on equity investment deal

There's another AI-doom post doing the rounds. This time, the S&P 500 dives nearly 40%.

Indices

377

There's another AI-doom post doing the rounds. This time, the S&P 500 dives nearly 40%.

A booming AI economy may be very bad for the broader economy, according to Citrini Research

Fed's Waller says next jobs report, not Supreme Court ruling, will be key for March interest rate decision

Finance

319

Fed's Waller says next jobs report, not Supreme Court ruling, will be key for March interest rate decision

The February jobs report, and not the Supreme Court ruling overturning a large part of President Donald Trump's tariffs on imported goods, will be key to w...

Congress must enact Trump's tariffs now to steer the U.S. away from a massive revenue cliff

Finance

235

Congress must enact Trump's tariffs now to steer the U.S. away from a massive revenue cliff

Tariffs need to become law or the federal budget will take a hit. Lawmakers have less than 150 days to decide.

Snowstorm hits airline stocks as total flight cancellations top 5,300

299

Snowstorm hits airline stocks as total flight cancellations top 5,300

Airline stocks are taking a hit as a major Northeast snowstorm is leading to thousands of flight cancellations.

Why Honeywell just shaved about $600 million off the price of a chemicals acquisition

236

Why Honeywell just shaved about $600 million off the price of a chemicals acquisition

Honeywell International on Monday received a 26% discount on its deal to acquire a business tied to the struggling chemicals industry.

Why JPMorgan says the international stock story still has legs

Finance

360

#Investment #inflation #stock market +2

Why JPMorgan says the international stock story still has legs

Decent growth, benign inflation, a dovish Fed and a weaker dollar all favor equities but international and emerging stocks look set to build on the outperf...

Novo Nordisk pitted a new weight-loss drug against Eli Lilly - and lost

Healthcare

314

Novo Nordisk pitted a new weight-loss drug against Eli Lilly - and lost

Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn't cut...

Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial

Healthcare

378

Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial

E-Commerce Buy Now Pay Later Industry Business Report 2026: A $40.88 Billion Market by 2030 with Amazon, Allianz, Bread Financial and Klarna Group Leading

Technology

442

E-Commerce Buy Now Pay Later Industry Business Report 2026: A $40.88 Billion Market by 2030 with Amazon, Allianz, Bread Financial and Klarna Group Leading

Key market opportunities for the e-commerce BNPL sector include expanding into emerging markets, leveraging partnerships with fintech, focusing on responsi...